Awarded Clinic of the Year 2026!

News

The world of medical cannabis is constantly changing – stay up to date with the latest law changes, clinical breakthroughs, and more with Curaleaf Clinic.

Authors

Research, News
22/11/2023

Cannabis Sativa is a complex plant containing hundreds of active components, including cannabinoids, terpenes, flavonoids and more. Medical ...

Research, News
16/11/2023

On 25th June 2018, the US Food and Drug Administration (FDA) approved Epidiolex, a cannabidiol (CBD)-based prescription medication, ...

News, Research
10/11/2023

Back pain is the leading cause of years lived with disability in industrialised countries, with the annual prevalence ...

Curaleaf Clinic, News
10/11/2023

At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions – such as chronic ...

Research, News
02/11/2023

Osteoarthritis (OA) is the most common of arthritic conditions. It is estimated to affect around 10 million people ...

News
01/11/2023

Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. ...

Research, News
26/10/2023

In recent years, interest in the therapeutic potential of cannabidiol (CBD) has skyrocketed. The cannabinoid has been investigated ...

Research, News
19/10/2023

Poor sleep is associated with several health problems, including hypertension, diabetes, obesity, depression, heart attack, and stroke. Sleep ...

News, Research
11/10/2023

Inflammatory Bowel Disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC) are conditions that are characterised by ...

Research, News
05/10/2023

Attention-deficit hyperactivity disorder (ADHD) is a behavioural condition characterised by impairing levels of inattention, hyperactivity, or impulsivity – ...

Research, News
29/09/2023

Cannabis Sativa L. is an extremely versatile plant that has been used for thousands of years for a ...

Research, News
21/09/2023

Rheumatic conditions such as osteoarthritis, rheumatoid arthritis, and lupus are thought to affect between 9.8% and 33.2% of ...